Pharma — India Trademark Cases
454 decisions indexed
Page 11 of 16 · 454 total
Sun Pharma Laboratories Ltd. v.Rainbow Life Sciences Pvt. Ltd.
The Bombay High Court passed an order granting leave to the petitioner and issuing a temporary injunction. The injunction restrained the respondent from dealing in medicinal preparations bearing the impugned trade mark "MONTEKAZ" or any deceptively similar mark, preventing passing off of the plaintiff's brand 'MONTEK'.
M/s.Apex Laboratories Pvt. Ltd. v.Bafna Biotech
M/s.Apex Laboratories Pvt. Ltd filed a civil suit against Bafna Biotech alleging trademark infringement, passing off, and copyright violation related to the 'ZINCOVIT' brand. The plaintiff sought permanent injunctions and damages due to the defendant using deceptively similar marks like ZINCOVITA on pharmaceutical products. Both parties ultimately reached a compromise, leading the Madras High Court to decree the suit based on the terms of the Memorandum of Compromise.
Elder Projects Ltd. v.Elder Labs Limited & Ors.
This Delhi High Court order addressed a trademark dispute concerning the use of 'Elder' on pharmaceutical products. The court heard statements from key executives of both parties, including those from Elder Projects Ltd. and Elder Labs Limited. While the plaintiff raised claims regarding unauthorized use, the court noted that it was of a prima facie view that the plaintiff had made false claims, reserving judgment on this matter for future hearings.
Wockhardt Limited v.Chematac Pharmaceuticals
Wockhardt Limited filed a Commercial IP Suit against Chematac Pharmaceuticals alleging passing off due to deceptively similar packaging. The court granted leave and passed an interim order restraining the defendant from using packaging that could mislead consumers into believing their product was associated with Wockhardt.
Sun Pharma Laboratories Ltd. v.Maxworth Pharma Pvt. Ltd.
Sun Pharma Laboratories Ltd. filed a suit against Maxworth Pharma Pvt. Ltd. regarding alleged trademark infringement concerning the medicinal preparation 'PANTOCID'. The Bombay High Court granted leave and further issued an ad-interim injunction restraining the defendant from using the deceptively similar trade mark "MAX PANTOCID" or any other similar marks.
Biofarma v.Bal Pharma Limited
The Delhi High Court dismissed Biofarma's suit against Bal Pharma Limited concerning passing off and trade dress infringement. The court found that the plaintiff could not claim exclusive rights over the term 'MEX' because it was an acronym ('Metformin Extended Release') derived from the principal drug ingredient, rendering it descriptive and publici juris in the pharmaceutical trade. Consequently, the defendant was permitted to continue using the mark without infringing on the plaintiff’s established brand.
Sun Pharmaceutical Industries Limited v.Systopic Laboratories Limited
The Delhi High Court allowed Sun Pharmaceutical Industries Limited to frame a new issue in its ongoing suit against Systopic Laboratories Limited. The core dispute involves the similarity between the trademarks 'STORVAS' and 'ORVAS'. Crucially, the court permitted the framing of an additional issue questioning the validity and potential cancellation of the defendant's trademark registration (No. 1328403). This decision was influenced by recent Supreme Court dicta emphasizing the necessity of addressing pleas of invalidity.
Magnolia Ltd. v.Softgel Health Care Pvt. Ltd.
The Bombay High Court granted a temporary injunction favoring Magnolia Ltd. against Softgel Health Care Pvt. Ltd. The court ordered that pending the final disposal of the suit, the defendant is restrained from manufacturing, selling, exporting, or using the disputed trademark 'VAGICLIN Plus' in connection with any pharmaceutical product. This interim order significantly protects the plaintiff's brand rights while the main infringement case proceeds.
Wockhardt Limited v.Torrent Pharmaceuticals Limited
The Supreme Court rejected Wockhardt Limited's appeal against a High Court Division Bench order that had granted an interim injunction based on passing off. The court found that the Division Bench correctly applied the triple test for passing off, establishing reputation and likelihood of confusion due to the minimal difference between the trade names. Despite arguments regarding acquiescence and prior conduct, the Supreme Court held that the balance of convenience favored the original judgment, thereby upholding the protection of Torrent's trademark.
Apollo Hospitals Enterprise Ltd. v.Naseer Apollo Pharmacy
The Madras High Court ruled in favor of Apollo Hospitals Enterprise Ltd. in a suit alleging trademark infringement and passing off by Naseer Apollo Pharmacy. The court found that the defendant's use of 'Apollo Pharmacy' was deceptive and infringed upon Apollo's registered trademarks across multiple classes, particularly in the pharmaceutical sector. Consequently, the plaintiff was granted permanent injunctions, ordered the surrender of all infringing materials, and directed the defendant to render accounts of profits.
Condore Health Care Pvt.Ltd v.M/S Corem Pharma Pvt Ltd
This case involved a Civil Revision Petition challenging the rejection of a suit filed under the Commercial Courts Act. The petitioner argued that since the estimated value of their intangible trademark rights and reliefs sought was less than one crore rupees, the court lacked jurisdiction. However, the respondent contended that the market value mentioned in the underlying Memorandum of Understanding (MOU) exceeded the threshold. The High Court ultimately ruled that for determining pecuniary jurisdiction under the Act, it is the value of the reliefs estimated by the plaintiff for the purpose of court fees that governs, not the higher market valuation cited elsewhere.
Galderma S.A And Anr v.Medsea Healthcare Pvt Ltd
The Delhi High Court dismissed the defendant's application seeking a summary dismissal of the trademark infringement suit. The court noted that while the plaintiffs had assigned their rights to the mark Q-MED, the timing and effect of this assignment were complex and required full trial evidence. Given the ongoing dispute over ownership changes and alleged concealment, the court ruled that the core issues could not be resolved summarily, allowing the main litigation to proceed.
Torrent Pharmaceuticals Ltd. v.Comed Chemicals Pvt. Ltd.
The Gujarat High Court dismissed Torrent Pharmaceuticals' appeal against a lower court order that vacated an interim injunction. The dispute centered on whether Comed Chemicals' brand name, 'CODROXIL', infringed upon Torrent's registered trademark, 'DROXYL'. Despite arguments regarding phonetic and visual similarity, the court found no prima facie case for confusion, noting that both names originated from the generic drug 'Cefadroxil' and considering the nature of prescription-only pharmaceutical sales. The appeal was dismissed, directing the lower court to finalize the main suit promptly.
Reliance Healthcare Pvt Ltd v.Reliance Medipharma
The Gujarat High Court addressed appeals concerning trademark infringement and passing off related to the brand name 'RELIANCE' in the pharmaceutical sector. While the court confirmed the lower court's decision refusing a broad injunction against the defendants using the name 'Reliance,' it partially allowed the appeal by specifically restraining the use of the derivative mark, 'Reliance Rx M,' for pharmaceutical products. This ruling highlights the nuanced approach courts take when balancing established trademark rights with specific usage limitations.
Apollo Hospitals Enterprise Ltd. v.Sri Sai Apollo Pharmacy
The Madras High Court ruled in favor of Apollo Hospitals Enterprise Ltd., finding that the defendant, Sri Sai Apollo Pharmacy, had infringed upon its registered trademarks ('Apollo', 'Apollo Pharmacy') and committed passing off. The court granted permanent injunctions restraining the defendant from using similar marks or services. Furthermore, the plaintiff was awarded costs and directed the defendant to surrender all infringing materials and render accounts of profits.
Sun Pharma Laboratories Ltd v.Lupin Ltd & Anr
The Delhi High Court confirmed an interim injunction in favor of Sun Pharma Laboratories Ltd against Lupin Ltd and others. The court found that the defendant's trade mark, TRI-VOBIT, was structurally and phonetically similar to the plaintiff’s registered mark, TRIVOLIB. Despite arguments regarding prior use of 'VOBIT,' the court ruled that the full marks must be compared, establishing a prima facie case for trademark infringement and passing off.
Ansari Bilal Ahmadlal Mohd. (Appellant) v.Shafeeque Ahmed Mohammad Sayeed (Respondent-Plaintiff)
The Bombay High Court dismissed the defendant's commercial appeal, upholding the original plaintiff's claim of passing off. The court found that a strong prima-facie case existed for passing off, despite differences in calligraphy and design elements. Considering the target audience—laborers with imperfect recollection—the court ruled that the defendant's use of 'SUKOON' was deceptively similar to the plaintiff's established brand, thereby protecting the plaintiff's proprietary rights.
Abbott Healthcare Pvt Ltd v.Raj Kumar Prasad & Ors
The Delhi High Court addressed an application by the plaintiff seeking a stay of infringement proceedings while rectification/cancellation proceedings against the defendant's trademark were pending. The court ruled that Section 124 of the Trade Marks Act requires the issue of invalidity to be formally raised and framed in the suit before a stay can be granted. Since the plaintiff failed to press this issue during the framing of issues, the application was dismissed, emphasizing procedural adherence over subsequent actions.
Optimus Pharma Pvt Ltd v.Rishabh Lohia & Anr
The Delhi High Court ruled in favor of Optimus Pharma Pvt Ltd in a passing off suit against Rishabh Lohia & Anr. The court found that the defendants dishonestly adopted the trade name 'Optimus' for pharmaceutical products, causing confusion in the market. Consequently, the plaintiff was granted permanent injunctions and awarded punitive damages of ₹3,00,000/- due to the defendant's evasion of court proceedings.
Modi- Mundipharma Pvt. Ltd. v.Union Of India & Anr.
The Delhi High Court addressed a challenge to the Intellectual Property Appellate Board's (IPAB) decision to de-register the trademark 'FECONTIN' due to alleged non-use. The court found that the IPAB overlooked a crucial fact: 'FECONTIN' was registered as an associated mark of 'FECONTIN F'. Citing Section 55(1) of the Trade Marks Act, the High Court held that the use of an associated trade mark can be accepted as equivalent to the use of the primary mark. Consequently, the court set aside the IPAB's order and remanded the matter for a fresh hearing.
Ajanta Pharma Ltd v.Uas Pharmaceuticals Pty Ltd & Another
The Calcutta High Court ruled in favor of Ajanta Pharma Ltd in a case involving the trademark 'Sunstop' for sun-screen cream. The court found that Uas Pharmaceuticals Pty Ltd had deliberately attempted to pass off its similar product as belonging to Ajanta, exploiting the plaintiff's established market reputation and substantial sales figures. Consequently, the court granted a decree restraining Defendant No. 1 from continuing this dishonest practice.
Torrent Pharmaceuticals Limited v.Wockhardt Limited And Anr
The Bombay High Court addressed a Notice of Motion concerning an action in passing off brought by Torrent Pharmaceuticals against Wockhardt. The court analyzed the 'classical trinity' of passing off, focusing on misrepresentation and reputation. Ultimately, the judge found that Torrent failed to establish a prima facie case for passing off due to the long co-existence of the rival products without any demonstrated confusion or deception. Consequently, the interim injunction sought by Torrent was dismissed.
Franco-Indian Pharmaceuticals Pvt. Ltd. v.Lupin Ltd And Anr
The Bombay High Court dismissed the appeal filed by Franco-Indian Pharmaceuticals against the refusal of interim relief. The dispute centered on alleged infringement and passing off concerning the medicinal preparation DEXORANGE, whose packaging and trade mark were copied by the respondents (Lupin Ltd And Anr). Despite strong claims regarding identical artistic work and deceptive similarity, the court found no immediate case for injunction after an 11-year delay in seeking relief. However, the court directed that the original suit be expedited, keeping all core issues of infringement and passing off open for future adjudication.
M/s. Eris Life Science Pvt.Ltd. v.M/s. Micro Labs Ltd
The Madras High Court ruled in favor of staying a trademark infringement suit when a rectification application concerning the registered mark is pending before the Intellectual Property Appellate Board (IPAB). The court clarified that the right to file for trademark rectification is a statutory right and cannot be curtailed by requiring prior leave or prima facie satisfaction from the civil court. Given the similarity between the marks and the pendency of the IPAB proceedings, the suit was stayed.
Cadila Healthcare Limited v.P.Ramu Trading as Skylane Pharmaceuticals
The Madras High Court ruled in favor of Cadila Healthcare Limited, a major pharmaceutical player, finding that the defendant's use of the trademark PANTOSKY constituted infringement against Cadila's registered mark PANTODAC. The court held that PANTOSKY was deceptively similar to PANTODAC, leading to a decree for permanent injunction and damages. This judgment reinforces the protection afforded to well-known pharmaceutical trademarks in the Indian market.
Cadila Pharmaceuticals Ltd. v.Medi Pharma & Another
The Delhi High Court ruled in favor of Cadila Pharmaceuticals Ltd. in a trademark infringement suit concerning the brand name 'POLYCAP'. The court granted a permanent injunction, preventing the defendants from manufacturing or marketing products under the disputed mark or any deceptively similar variation. This decision underscores the importance of protecting established pharmaceutical trademarks and maintaining consumer trust regarding product efficacy.
Mankind Pharma Limited v.Sun Pharma Laboratories Limited
Mankind Pharma Limited challenged an order regarding territorial jurisdiction in its trademark infringement suit against Sun Pharma Laboratories Limited. The core dispute centered on whether the plaintiff could file the suit in Chennai, given that the defendant claimed no sales or office presence there. The Madras High Court ultimately dismissed the appeals, finding that the appellant's actions and disclosures indicated a sufficient connection to the local jurisdiction.
M/s. Cavinkaare Private Limited v.Panchaksharam Guru Moorthy
The Madras High Court addressed a complex dispute between M/s. Cavinkaare Private Limited and Panchaksharam Guru Moorthy regarding the trademarks 'KARTHIKA' and 'KARTIKA'. The litigation, which involved claims of infringement and passing off across multiple suits, was ultimately resolved through a Joint Compromise Memo. The court decreed C.S.No.204/2012 based on this compromise, granting Cavinkaare exclusive rights to the trademark in relevant goods and services while dismissing the counter-suit (C.S.No.467/2012).
M/s.Advaith Bio Remedies v.The Registrar Of Trademarks
M/s. Advaith Bio Remedies approached the Madras High Court seeking intervention regarding the undue delay in processing their trademark application for 'BIO CARE' (Application No. 3040849). The petitioner, which manufactures Ayurvedic medicines, argued that the prolonged wait was negatively impacting their business operations. The court intervened by issuing a Writ of Mandamus, directing the Registrar of Trademarks to prioritize and dispose of the pending application as expeditiously as possible.
Roche Products (India) Pvt Ltd v.Drugs Controller General Of India
Roche Products, the originator of the biological drug Trastuzumab (marketed globally under HERCEPTIN®), filed a suit seeking injunction against competitors launching purported biosimilars like CANMAb and HERTRAZ. The plaintiffs contended that these drugs were being misrepresented as 'Trastuzumab' or similar to HERCEPTIN®, without following proper regulatory guidelines for biologics. The court issued an interim order, restraining the defendants from making misleading claims and using proprietary data until the final decision on bio-similarity is reached.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.